Evidence map›Paper›PMID 41295069›Full record

ReviewJournal of functional biomaterials2025

Magnetic Hydrogels as a Treatment for Oncological Pathologies.

Veronica Manescu Paltanea, Adrian-Vasile Dumitru, Aurora Antoniac, Iulian Antoniac, Gheorghe Paltanea, Elena-Cristina Zeca Berbecar, Mirela Gherghe, Iosif Vasile Nemoianu, Alexandru Streza, Costel Paun and 1 more

Abstract readReview
In one paragraph

Review in Journal of functional biomaterials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Veronica Manescu PaltaneaFaculty of Material Science and Engineering, National University of Science and Technology Politehnica Bucharest, 313 Splaiul Independentei, District 6, RO-060042 Bucharest, Romania.ORCID 0000-0002-2535-5698
Adrian-Vasile DumitruDepartment of Pathology, University Emergency Hospital, RO-030167 Bucharest, Romania.ORCID 0000-0003-3784-7355
Aurora AntoniacFaculty of Material Science and Engineering, National University of Science and Technology Politehnica Bucharest, 313 Splaiul Independentei, District 6, RO-060042 Bucharest, Romania.
Iulian AntoniacFaculty of Material Science and Engineering, National University of Science and Technology Politehnica Bucharest, 313 Splaiul Independentei, District 6, RO-060042 Bucharest, Romania.ORCID 0000-0003-0112-3494
Gheorghe PaltaneaFaculty of Electrical Engineering, National University of Science and Technology Politehnica Bucharest, 313 Splaiul Independentei Street, District 6, RO-060042 Bucharest, Romania.ORCID 0000-0003-3251-7146
Elena-Cristina Zeca BerbecarEstet Laser Clinique, 11 Str. Calusei, RO-030167 Bucharest, Romania.
Mirela GhergheNuclear Medicine Department, University of Medicine and Pharmacy "Carol Davila", RO-050474 Bucharest, Romania.ORCID 0000-0003-4293-0428
Iosif Vasile NemoianuFaculty of Electrical Engineering, National University of Science and Technology Politehnica Bucharest, 313 Splaiul Independentei Street, District 6, RO-060042 Bucharest, Romania.ORCID 0000-0001-5610-8318
Alexandru StrezaFaculty of Material Science and Engineering, National University of Science and Technology Politehnica Bucharest, 313 Splaiul Independentei, District 6, RO-060042 Bucharest, Romania.
Costel PaunNational Institute for Research and Development in Microtechnologies IMT-Bucharest, 126A Erou Iancu Nicolae Street, RO-077190 Bucharest, Romania.
Sebastian GradinaruDepartment of Medical-Clinical Discipline, Faculty of Medicine, Titu Maiorescu University, 67A Gheorghe Petrascu, RO-031593 Bucharest, Romania.

Funding

Ministry of Research, Innovation, and Digitization, CNCS - UEFISCDI, PNCDI IV PV-IV-P1-PCE-2023-1452
6 · The paper itself

Abstract

Cancer is considered today as a prevalent research direction due to the fact that, by 2050, more than 30 million cases will occur, followed by about 19 million deaths. It is expected that scholars will search for new, innovative, and localized therapies to ensure a much more targeted treatment with reduced side effects. Magnetic hydrogels overcome the disadvantages of classical magnetic nanoparticles in various oncological domains, including magnetic hyperthermia, theragnostic, immunotherapy, and, notably, regenerative medicine and contrast substances. We will review the magnetic hydrogel topics that may be involved as a potential application for cancer. Firstly, we present the international context and subject importance in the framework of statistics estimated by some researchers. Then, the magnetic hydrogel synthesis method will be briefly described with examples extracted from the literature. Supplementary, we will emphasize the main attributes of an ideal magnetic hydrogel, and last but not least, we will review some of the latest in vitro and in vivo studies in a direct relationship with magnetic hyperthermia, chemotherapeutic drug release dynamics, and immunotherapy used as single strategies or in combination, by underling the magnetic properties of the hydrogels and importance of application of magnetic fields. We will conclude our review paper by discussing toxicity issues, future trends, limitations, and proposed new approaches to address them.

Indexed as

cancer treatmentcontrolled drug releaseimmunotherapymagnetic field guidancemagnetic hydrogelmagnetic hyperthermiaoncologysaturation magnetization

Identifiers

PMID41295069
PMCPMC12653677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.